Abstract Bone morphogenetic protein (BMP) is commonly used as an ICBG substitute for transforaminal lumbar interbody spine fusion (TLIF). However, multiple recent reports have raised concerns regarding a substantial incidence of perioperative radiculopathy. Also, given the serious complications reported with anterior cervical BMP use, risks related to swelling and edema with TLIF need to be clarified. As TLIF related complications with rhBMP-2 have generally been reported in small series or isolated cases, without a clear denominator, actual complication rates are largely unknown. The purpose this study is to characterize perioperative complications and complication rates in a large consecutive series of TLIF procedures with rhBMP-2. We reviewed inpatient and outpatient medical records for a consecutive series of 204 patients [113 females, 91 males, mean age 49.3 (22-79) years] who underwent TLIF using rhBMP-2 between 2003 and 2007. Complications observed within a 3-month perioperative interval were categorized as to etiology and severity. Wound problems were delineated as wound infection, hematoma/seroma or persistent drainage/ superficial dehiscence. Neurologic deficits and radiculopathies were analyzed to determine the presence of a clear etiology (screw misplacement) and identify any potential relationship to rhBMP-2 usage. Complications were observed in 47 of 204 patients (21.6%) during the 3-month perioperative period. Major complications occurred in 13 patients (6.4%) and minor complications in 34 patients (16.7%). New or more severe postoperative neurologic complaints were noted in 13 patients (6.4%), 6 of whom required additional surgery. These cases included one malpositioned pedicle screw and one epidural hematoma. In four patients (2.0%), localized seroma/hematoma in the area of the foramen caused neural compression, and required revision. In one additional patient, vertebral osteolysis caused foraminal narrowing and radiculopathy, but resolved without further surgery. Persistent radiculopathy without clear etiology on imaging studies was seen in six patients. Wound related problems were seen in six patients (2.9%), distributed as wound infection (3), hematoma/seroma (1) and persistent drainage/dehiscence (2). Overall, this study demonstrates a modest complication rate for TLIF using rhBMP-2. While perioperative complications which appeared specific to BMP usage were noted, they occurred infrequently. It will be necessary to weigh this incidence of complications against the complication rate associated with ICBG harvest and any differential benefit in obtaining a solid arthrodesis.
Introduction
In 1982, Harms and Rollinger [1] introduced a modification to the posterior lumbar interbody fusion (PLIF) technique that has come to be termed transforaminal lumbar interbody fusion (TLIF). TLIF has since gained popularity due to the need for significantly less nerve root retraction which was associated with a high complication rate for PLIF [2] [3] [4] [5] .
Since its approval by the Food and Drug Administration (FDA) in 2002, rhBMP-2 (INFUSE, Medtronic, Memphis, Tennessee) has had a significant impact on spinal surgery. Despite being approved only for anterior interbody fusion with an LT cage (Medtronic, Memphis, Tennessee), rhBMP-2 has been used largely in an ''off-label'' manner [6] . Several studies have demonstrated the successful use of rhBMP-2 in TLIF and posterolateral fusion [7] [8] [9] [10] [11] . However, recent reports of a high complication rate in anterior cervical fusion [12] [13] [14] have raised concerns regarding the use of rhBMP-2 for any application.
Complications have been reported in up to 35% of cases with the use of rhBMP-2 in TLIF [7, 15, 18, 19] . These complications include CSF leak, hematoma, pedicle screw malposition, neurologic deficit and radiculitis. Unfortunately, most of the existing studies on TLIF have been limited, in that they have reported complications as isolated cases or small case series. It is important to examine these complications in consecutive patients in order to establish a clear denominator especially due to the increasing use of rhBMP-2 in TLIF. Therefore, the purpose of this study was to review a large consecutive series of patients undergoing TLIF with rhBMP-2 in order to characterize the perioperative complications associated with the procedure, and those complications related specifically to rhBMP-2 use.
Methods
We reviewed medical records in a consecutive series of 204 patients who underwent TLIF using rhBMP-2 between 2003 and 2006. Demographic data included age, gender, smoking history, comorbidities, and diagnosis. Surgical data included operative time, estimated blood loss, fusion levels, rhBMP-2 kit size as well as any other bone graft extenders. Perioperative data consisted of number of days in the ICU or TCU, overall hospital length of stay, and discharge disposition.
Complications within a 3-month perioperative period were categorized as to their etiology and severity. Major complications were defined as those which were potentially life threatening, required reoperation in the perioperative period or left some permanent injury. Minor complications were those events which required additional intervention but did not significantly alter the course of treatment. Medical complications were attributed to the surgical procedure if they occurred during the 3-month perioperative period, whereas complications potentially related to rhBMP-2 were included regardless of the time frame.
Wound related problems were classified as wound infection, hematoma/seroma, or superficial dehiscence/ suture reaction. Wound infections were defined by the need for surgical debridement and subsequent antibiotic treatment, regardless of culture results. Fluid collections which were clinically evident, but resolved without treatment, or underwent drainage with negative cultures and no antibiotic treatment were characterized as hematoma/seroma. Superficial wound drainage was the description applied to cases of suture reaction or superficial dehiscence which was managed as an outpatient with local care and went onto adequate wound healing, with or without oral antibiotic coverage.
Neurologic deficits and radiculopathies were analyzed to determine the presence of a clear etiology and identify any potential relationship to the use of rhBMP-2. Particular attention was paid to the development of new, contralateral, or more severe leg pain postoperatively. Postoperative imaging was reviewed and any indication of heterotopic fluid collection or bone formation was sought.
All patients underwent open single or two-level TLIF by one of our institution's six surgeons. A standard posterior midline approach was made with subperiosteal dissection. After placement of pedicle screws, a unilateral facetectomy was performed. The side of the transforaminal approach was selected based on the patients more symptomatic leg pain. The annulus was then incised and the disk removed. rhBMP-2 combined with local autograft, iliac crest bone graft and/or various bone graft extenders were placed in the interbody space along with a polyetheretherketone (PEEK) cage. In the majority of cases where one large or one small sponge was used, the rhBMP-2 soaked ACS was divided into three. One-third of the sponge was placed in the disc space, and one-third was placed in either lateral gutters. Thus, in the majority of patients (95.6%) the dose of rhBMP-2 in the interspace was 4 mg, but ranged from 1.4 to 6 mg. Placing rhBMP-2 posteriorly in the disk space was avoided. Rods were then contoured in lordosis and placed into position. Bone graft with or without extender and rhBMP-2 were placed in the lateral gutters. The wound was closed in layers in standard fashion over a drain.
Results
The study cohort of 204 patients (Table 1) included 91 men and 113 women with a mean age of 49.3 years (range 22-79). The mean follow-up was 29.8 ± 9.0 months. Indication for surgery included spondylolisthesis (27%), instability (5.4%), stenosis (10.8%), scoliosis (2.9%), disc pathology (26%), non-union (1.5%), adjacent level degeneration (8.3%) and post-discectomy instability (18.1%). Eighty-three patients (40.7%) were smokers.
One hundred sixty-three (79.9%) underwent single-level fusions and 41 (20.1%) two-level fusions. The mean operative time was 278 min (range 132-568) with a mean estimated blood loss of 692.8 cc (range 60-3,000). A large INFUSE kit was used in 195 (95.6%) cases. Two cases (1%) used a single small kit, 6 (2.9%) used two large kits, and 1 (0.5%) used three large kits. Iliac crest bone graft was taken in 45 (22.1%) patients and local bone graft was used in 174 (85.3%). Various other bone graft extenders used consisted of allograft (24%), mastergraft ceramic (10.3%), and demineralized bone matrix (33.8%).
Complications were observed in 47 of 204 cases (21.6%) with 13 (6.4%) major and 34 (16.7%) minor complications. Major surgical complications were pneumonia (1), vascular injury (1), neurologic complications (7), wound infection (3), and wound hematoma/seroma (1) ( Table 2, 3) .
New or worsening perioperative neurologic complaints were noted in 13 patients (6.4%), 6 of whom needed additional surgery, including 1 malpositioned screw and 1 epidural hematoma. In 4 patients (2%), a seroma located in the area of the foramen caused neural compression, requiring revision (Fig. 1) . In all these cases the radiculopathy were on the same side as and corresponded to the dermatomal distribution of the TLIF window. These patients started to complain of radiculopathy an average of 1.7 ± 1.9 months after surgery and their symptoms improved in an average of 4.0 ± 2.8 months after the evacuation of the seroma surrounding the nerve root. Of the seven patients who received more than a single large Infuse kit, only one patient presented with a postoperative radiculopathy and hematoma on the TLIF side that required an operative evacuation. In one patient, vertebral osteolysis, foraminal narrowing and radiculopathy resolved 6 months after surgery without further surgery or the need for revision.
Six patients (2.9%) had persistent radiculopathy without a clear etiology on imaging studies and required no additional surgery. The radiculopathy in these cases were on the same side as and corresponded to the dermatomal distribution of the TLIF window as well, with an average time of presentation of 1.7 ± 1.9 months after surgery. These patients were treated with oral steroids and Gabapentin (Pfizer, New York, NY) or Pregabalin (Pfizer, New York, NY, USA). The radiculopathy resolved in an average of 4.0 ± 2.8 months after the index surgery.
Wound related problems were seen in six patients (2.9%): three deep wound infections, one wound hematoma/seroma, and two dehiscences. Ileus (6), urinary tract infection (2) and other (18) minor complications were also observed.
Discussion
Circumferential lumbar fusion has been used to treat a number of spinal problems including degenerative disc disease, spondylolisthesis, and pseudarthrosis. It is associated with high rate of fusion and can provide a biomechanical advantage to a posterior-only fusion [20] . Methods for this 360 fusion have complications, however. Complication rates up to 77% have been reported with anteroposterior reconstruction for lumbar disc degeneration and instability [15] [16] [17] and up to 51% in PLIF [4] . Complications associated with TLIF have occurred at nearly half these rates [7, 15, 18, 19] . In addition, a financial analysis by Whitecloud [21] of TLIF versus anterior-posterior fusion found that TLIF had an average cost savings of approximately $15,000 per admission. Therefore, TLIF provides an appealing and potentially cost-effective approach to circumferential lumbar fusion. rhBMP-2 has been reported to result in larger and more robust fusions when compared to autograft. Lower operative time and blood loss have been reported [10, 22, 23] . Consequently, its use has risen since FDA approval in 2002, but largely in an ''off-label'' manner [6] . Recent reports of complications with use of rhBMP-2 in anterior cervical fusions [12] [13] [14] and a subsequent FDA warning letter [24] regarding the use of cervical rhBMP-2 have fueled concerns over the use of rhBMP-2 in any application. Therefore, concern remains with the use of rhBMP-2 in TLIF.
In a study using rhBMP-2 in posterior lumbar interbody fusion (PLIF), Haid et al. [25] reported bone formation outside the disc space and into the spinal canal or neuroforamen in nearly 75% of patients. Heterotopic bone was demonstrated in 20.8% in minimal access interbody fusion with rhBMP-2 in a study by Joseph et al. [26] . Conversely, Villavicencio et al. [7] in a series of 74 consecutive patients found no incidence of ectopic bone formation. In the FDA Investigational Device Exemption Study of anterior lumbar interbody fusions with rhBMP-2 and an LT cage [27] , there were no reports of ectopic bone formation, implying that the intact annulus may posteriorly provide a barrier to the leaching of BMP into the spinal canal.
Various technical modifications have been described to try to minimize unwanted bone formation and the potential for neurologic sequelae. Villavicencio [7] placed the rhBMP-2 and autograft anterior to the structural allografts. More recently, Rihn et al. [19] noted a decreased rate of postoperative radiculitis following the use of a hydrogel sealant posterior to the interbody cage. Further studies are needed, however, to clarify if these technical modifications can reduce complications.
The specific cause of new neurologic complaints following TLIF remains unclear. Nerve root retraction and injury during cage insertion are possible. Theories exist attributing it to ectopic bone formation in the neuroforamen or a rhBMP-2-induced inflammatory reaction near the nerve root. The reported rates of postoperative radiculitis with TLIF using autograft have ranged from 2 to 7% [7, 15, 18, 19, 32] Fig . 1 35-year-old female with L5-S1 spondylolisthesis treated with transforaminal interbody fusion using a PEEK cage and rhBMP-2/ ACS. 3 months after surgery, patient complained of increasing right leg pain. a Axial CT scan and b sagittal reconstruction at 3 months demonstrates a cyst with a bony capsule in the disc space intruding into the L5-S1 neuroforamen. The patient required revision foraminotomy and cyst resection. Intraoperatively, the cystic structure was noted to be calcified and embedded in the disc space Eur Spine J (2011) 20:612-617 615 [19, [28] [29] [30] [31] . In contrast, radiculitis occurs at a rate of 7-14% when rhBMP-2 has been used [7, 15, 18, 19, 32] . In our series, 13 patients (6.4%) presented postoperatively with new or worsened radiculopathy. Of that group, we believe that five patients (2.5%) demonstrated radiographic and clinical findings characteristic of rhBMP-2-induced compression in the area of the TLIF window. There was localized seroma in the foramen causing root compression on the same side as and corresponding to the dermatomal distribution of the TLIF window. The remaining 8 patients (4%) with radiculopathy without radiographic evidence are consistent with previously reported rates without the use of rhBMP-2. Vertebral osteolysis has been well described after the use of rhBMP-2 in lumbar interbody fusion. Toth et al. [33] recently reported transient osteoclastic activity in sheep distal femora which was related to increasing dosage of rhBMP-2. Vaidya et al. [34] found an 82% rate of end plate resorption in evaluating rhBMP-2 with polyetheretherketone (PEEK) cages. Vertebral bone resorption was demonstrated on CT scan in 69% of cases in a study by McClellan et al. [35] , but not all these patients were symptomatic. Lewandroski et al. [36] found only a 7% incidence in single-level TLIFs with rhBMP-2. Our study found only one patient (0.5%) who showed radiographic evidence of osteolysis as well as foraminal narrowing and radiculopathy. It is unclear whether this is specifically attributable to the rhBMP-2 alone, due to surgical technique resulting in endplate violation, or a combination of both. Deep wound infection or hematoma/ seroma was seen in four patients (2%) which is similar to the reported deep infection rates between 2.5 and 3.6% [7, 15, 19] .
The major limitation of this study was its retrospective design. We also did not have a contemporaneous control group to compare our results. There was also difficulty in characterizing postoperative radiculopathy in the absence of positive imaging. It is unclear whether this was a true surgical complication or persistence of the preoperative pathology.
In summary, this study of 204 patients demonstrates a modest complication rate for TLIF using rhBMP-2, with rhBMP-2-associated complications occurring infrequently. It will be necessary to weigh this incidence of complications against the complication rate associated with iliac crest bone graft harvest and any differential benefit in obtaining a solid arthrodesis.
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